Johnson County Clin Trials

A Phase 1/2, randomized, controlled study to evaluate the reactogenicity, safety, and immunogenicity of an investigational Flu Seasonal/SARS-CoV-2 mRNA combination vaccine in adults.

A phase 2 randomized, observer-blind, dose-finding study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in younger and older adults

A Phase 2b Randomized, Double-blind, Placebo-controlled, Multicenter Dose Ranging Study to Evaluate Efficacy and Safety of CD388, a Novel Long-acting Antiviral Conjugate, for the Prevention of Influenza in Subjects not at Risk for Influenza Complications

A Phase 3, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of mRNA-1403, a Multivalent Candidate Vaccine to Prevent Norovirus Acute Gastroenteritis in Adults ≥18 Years of Age

A Phase 3, Randomized, Observer-blind, Active-controlled, Case-driven Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared with a Licensed Inactivated Seasonal Influenza Vaccine in Adults ≥50 Years of Age

A Phase 1, first-time-in-human (FTiH), observerblind, randomized, controlled study to evaluate the safety, reactogenicity and immune response of various doses of an mRNA-based respiratory syncytial virus (RSV) investigational vaccine in healthy participants 18–45 years of age.